Connect with us

Technology

Menarini’s cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw

Published

on

Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the potential for an automated system to deliver genomic profiles of fetal cells that is highly concordant with the genomic analysis obtained from invasive procedures. Results of a large clinical validation study show that Menarini Silicon Biosystems’ fetal cell based noninvasive prenatal screening (NIPT) technology can accurately detect both fetal genome-wide pathogenic copy number variants greater than 600Kb in size and the commonly screened trisomy conditions.

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., July 2, 2024 /PRNewswire/ –The Reproductive Precision Medicine Unit of Menarini Silicon Biosystems (MSB) presented last week, at the 21st World Congress of the Fetal Medicine Foundation meeting in Lisbon, Portugal, results of a large multicenter study describing their next generation non-invasive prenatal testing technology using fetal cells isolated from maternal blood. The genomic analysis of these fetal cells showed a high concordance with the analysis of fetal cells obtained from invasive diagnostic procedures. Moreover, MSB’s cell-based test, under development, demonstrated its potential validity for screening genomic conditions not easily found with currently available, state of the art, non-invasive screening technologies based on cell-free DNA (cfDNA) analysis.

This large study, which enrolled over 1,000 women, was centered on isolating individual fetal (trophoblast) cells from maternal blood and analyzing them for both common trisomic conditions and genome-wide microdeletions and microduplications, called pathogenic copy number variants (pCNVs), that account for significant perinatal morbidity and mortality. The results presented showed that MSB’s fetal cell based NIPT could deliver information beyond core “common” trisomies detected by standard non-invasive cfDNA analysis, as well as detect with a high level of accuracy and granularity genome-wide microdeletions and microduplications down to a size of at least 600Kb. The cell-based test was compared with chromosomal microarray analysis (CMA) and karyotype from chorionic villus sampling (CVS) or amniocentesis, the clinical gold – standard fetal diagnostic methodologies to detect genomic chromosomal abnormalities in the prenatal setting.

According to Professor Jon Hyett, Head of Maternal and Fetal Medicine at Liverpool Hospital and Professor of Obstetrics and Gynaecology at Western Sydney University, who looks after pregnancies that have a high risk of complication – either for the mother, or for the fetus: “This data is exciting because it shows the potential to deliver clinically relevant and actionable information about fetal genomic abnormalities  at higher resolution and accuracy than existing screening tests and at an early gestational age when almost no pCNVs are currently detected.” Menarini’s new study thereby opens the door to a whole new paradigm in prenatal screening.

For Thomas Musci, MD, Chief Medical Officer, Head of Menarini Silicon Biosystems’ Reproductive Precision Medicine Business Unit, who presented the results of the study, “Isolating intact fetal cells from maternal blood for prenatal screening has  long been perceived as an extremely challenging goal. Our highly automated system for the isolation and single–cell analysis of circulating extravillous trophoblasts (cEVTs) supports the feasibility of a cell–based NIPT for fetal genomic profiling that can lead to more informed decision-making at all levels.”

Menarini has been actively investing to advance single cell analysis and sequencing in the field of reproductive care. For Fabio Piazzalunga, President of Menarini Silicon Biosystems, “The results of this study, which confirmed the potential ability of our cell based NIPT to identify fetal abnormalities with high sensitivity, accuracy, and specificity, show the potential of Menarini to significantly impact women’s health. Our continuous commitment and efforts to advance our scientific findings in this field aim to provide, in the future, a potentially revolutionary solution that brings more information to women and their doctors”. These new activities fully support the company’s vision to become a leader in minimally invasive cell-based applications that can allow for easier, faster, and more precise diagnostic and therapeutic approaches in multiple therapeutic areas.

About Menarini Silicon Biosystems (MSB)

MSB offers unique rare cell technologies and solutions that provide clinical researchers with access to unparalleled resolution in the study of cells and their molecular characterization.

Menarini Silicon Biosystems, based in Castel Maggiore (Bologna, Italy), and Huntingdon Valley, PA., U.S., is a wholly owned subsidiary of the Menarini Group, a multinational pharmaceutical, biotechnology and diagnostics company headquartered in Florence, Italy, with more than 17,000 employees in 140 countries.

Logo: https://mma.prnewswire.com/media/2452172/Menarini_Silicon_Biosystems_Logo.jpg

Contact:
PAVY Consulting
Linda PAVY
lipavy@pavyconsulting.com 

View original content:https://www.prnewswire.co.uk/news-releases/menarinis-cell-based-non-invasive-prenatal-technology-demonstrates-high-resolution-detection-of-fetal-genomic-abnormalities-from-a-simple-maternal-blood-draw-302187230.html

Continue Reading

Technology

NAVER D2SF Invests in On-Device AI Startup TraceWeave

Published

on

By

TraceWeave develops its own post-Transformer AI architecture that enables AI agents to run on memory-constrained devicesCompletes paid pilot in mobility; pursues commercialization across robots, drones, smart glasses, and moreNAVER D2SF continues to invest in on-device AI and next-generation device technologies

SEOUL, South Korea, Oct. 20, 2026 /PRNewswire/ — NAVER D2SF has made a new investment in TraceWeave, an on-device AI startup led by co-founder and CEO Jaeyoung Park. TraceWeave is the team behind Phase-TITAN, a post-Transformer architecture that understands long contexts and carries out multi-step tasks while keeping memory usage constant. NAVER D2SF recognized the company’s core technology for enabling AI agents on resource-constrained devices.

As AI expands to robots, vehicles, smart glasses, and drones, its applications are advancing beyond simple chatbots toward complex reasoning and decision-making. In Transformer-based models, the key-value cache (KV-Cache) grows with context length, requiring more memory. On-device constraints in memory, battery life, and heat have made it difficult to implement AI agents that understand long contexts and perform complex tasks.

TraceWeave’s Phase-TITAN is a new AI architecture designed to resolve this memory bottleneck by replacing the conventional Transformer architecture altogether. TraceWeave develops its own AI models rather than relying on existing open-source models. Memory usage remains constant as context grows. According to TraceWeave, at a 1M-token context without quantization, a comparable Transformer’s KV-Cache holds tens of gigabytes or more, while its 1B Phase-TITAN model holds 0.04 GB. This enables agents to call tools, interpret results, and decide on their next actions entirely on the device, without cloud calls. TraceWeave’s internal benchmarks on RULER and BFCL indicate that Phase-TITAN maintains performance on par with Transformer models of the same size and larger.

TraceWeave has demonstrated a multi-step agent running on a smartphone using only its CPU, without cloud calls. In mobility, it completed a paid pilot with the autonomous driving affiliate of a global automotive group, identifying driving-data frames that improve the partner’s autonomous driving model without human annotation. It is also validating in-vehicle agent performance with a global automotive electronics software company and exploring opportunities in robots, drones, smart glasses, and wearables. TraceWeave was a Top 20 finalist in NVIDIA’s 2026 Inception Grand Challenge.

TraceWeave was co-founded in October 2025 by researchers with backgrounds at ETH Zurich, Google, and KAIST. The team combines engineering expertise grounded in computational neuroscience and physics with business development capabilities, designing its own architecture and validating it in device environments that reflect real-world customer needs. In this seed round led by Mirae Asset Capital, TraceWeave raised approximately KRW 3 billion at a pre-money valuation of approximately KRW 30 billion. Based at NAVER D2SF @Gangnam, the company plans to use the funding to expand its research and engineering team for next-generation architecture development and grow its business.

“Taking the KV cache out was never the hard part. Staying capable without it was,” said Jaeyoung Park, co-founder and CEO of TraceWeave. “The best part is no part. Phase-TITAN already delivers Transformer-class capability without the Transformer’s memory tax, and the next one goes well beyond its class, with the memory still fixed.”

“On-device AI is a core technology for implementing complex, advanced AI across diverse device environments beyond PCs, and it also offers advantages in reducing cloud call costs and protecting privacy,” said Sanghwan Yang, Head of NAVER D2SF. “TraceWeave is a team that is innovating AI architecture to overcome the limitations of existing AI models and bring AI to on-device environments.”

View original content:https://www.prnewswire.com/news-releases/naver-d2sf-invests-in-on-device-ai-startup-traceweave-302913752.html

SOURCE NAVER D2SF

Continue Reading

Technology

Gear Up for Year-End Wellness: iHerb Spotlights 4 Everyday Health Essentials and Kicks Off 11.11 Early Access Sale with Up to 40% Off Sitewide

Published

on

By

HONG KONG, Oct. 21, 2026 /PRNewswire/ — As October gets underway, many individuals are proactively preparing their daily health and self-care routines ahead of the busy year-end season. Global health and wellness e-commerce platform iHerb has curated a premier lineup of four top-selling daily nutritional supplements from its flagship house brand, California Gold Nutrition, and consumer-favorite brand, Doctor’s Best. Encompassing marine collagen, Omega-3 fatty acids, CoQ10, and chelated magnesium, this selection addresses distinct nutritional priorities, providing consumers with comprehensive, high-quality choices for daily maintenance and holistic vitality.

The iHerb Singles’ Day Early Access campaign officially launches today and runs through October 28. During the promotional period, shoppers can apply promo code “HD11BUY” at checkout to receive up to 40% off sitewide. Additionally, new customers worldwide can use promo code “WELCOME7” to enjoy 30% off their first purchase—offering consumers the ideal opportunity to proactively map out their year-end wellness and nutrition regimens.

Daily Wellness from Within: Collagen and Omega-3 as Nutritional Building Blocks

Founded in the United States and powered by 30 years of global health curation, iHerb offers an extensive catalogue spanning vitamins, dietary supplements, beauty, sports nutrition, and everyday lifestyle essentials. The platform empowers consumers to explore premier wellness goods from around the world all in one convenient place.

Among the featured highlights is California Gold Nutrition’s Hydrolyzed Marine Collagen Peptides + Hyaluronic Acid and Vitamin C. This synergistic formula pairs bioavailable hydrolyzed marine collagen peptides with hyaluronic acid and antioxidant vitamin C. Formulated as an unflavored, easily dissolvable powder, it blends effortlessly into morning coffee, smoothies, or water according to usage guidelines, offering a hassle-free addition to daily beauty and mobility regimens.

For essential fatty acid support, California Gold Nutrition’s Omega-3 Premium Fish Oil provides concentrated Omega-3 fatty acids, specifically EPA and DHA. Delivered in fish gelatin softgels, it offers an accessible, high-purity option for consumers seeking to incorporate vital fatty acids into their daily dietary routine to maintain overall cardiovascular, cognitive, and cellular wellness.

Targeted Cellular Vitality and Essential Minerals: Advanced Science from Doctor’s Best

Complementing collagen and fish oil, trusted wellness brand Doctor’s Best delivers science-backed formulations for more specialized nutritional support. The brand’s High Absorption CoQ10 utilizes naturally fermented Coenzyme Q10 paired with patented BioPerine® black pepper extract to enhance nutrient absorption and bioavailability. It provides an exceptional daily option for adults focused on supporting cardiovascular function, cellular energy generation, and antioxidant defenses.

Another standout favorite is Doctor’s Best High Absorption Magnesium Lysinate Glycinate, which features Albion® TRAACS® chelated magnesium in convenient tablet form. This fully chelated delivery ensures high bioavailability and superior digestive tolerance, allowing consumers to easily select the right daily supplement tailored to their dietary habits, physical activity, and relaxation needs.

Special Promotion: 11.11 Early Access

Sitewide Early Bird Offer: Use promo code HD11BUY to take up to 40% off sitewide.

New Customer Welcome: First-time shoppers globally can apply promo code WELCOME7 for 30% off their order.Promotion Window: Active immediately through October 28, 2026.Details & WhatsApp: Subject to terms and product eligibility on the official iHerb website. Subscribe to the official iHerb Hong Kong WhatsApp channel for real-time campaign updates.

About iHerb (https://hk.iherb.com/)

iHerb is a world-leading e-commerce destination dedicated to health, wellness, and self-care. Founded in California in 1996, iHerb now serves millions of customers across more than 180 countries. With a selection of over 40,000 authentic, high-quality products across vitamins, supplements, sports nutrition, personal care, and grocery items, iHerb delivers value and convenience directly to doorsteps worldwide, supported by state-of-the-art GMP-registered, climate-controlled distribution centers.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/gear-up-for-year-end-wellness-iherb-spotlights-4-everyday-health-essentials-and-kicks-off-11-11-early-access-sale-with-up-to-40-off-sitewide-302914770.html

SOURCE iHerb

Continue Reading

Technology

EPG Showcases Full-Stack AIDC Capabilities and Global Delivery Network at DCWA 2026 in Singapore

Published

on

By

SINGAPORE, Oct. 21, 2026 /PRNewswire/ — EPG, a global provider for prefabricated modular data center infrastructure, showcased its latest AI data center solutions at Data Centre World Asia (DCWA) 2026, held in Singapore on September 29–30. Demonstrating its commitment to Asia-Pacific and the markets beyond, EPG presented its AI Core prefabricated modular data center solution and Edge POD prefabricated edge data center solution, alongside the global launch of AeroLev 1850, an air-cooled, magnetic-bearing chiller platform jointly introduced with MagPro. Together, these offerings demonstrate EPG’s end-to-end capabilities across modular infrastructure and high-efficiency cooling for AI data centers (AIDCs).

At the opening address for the Critical Infrastructure Theatre, EPG Chief Operating Officer Johnny Zhang highlighted the growing demands AI is placing on data center infrastructure, from higher power density and faster deployment to more efficient cooling. As AI continues to evolve, infrastructure must keep pace to support the next generation of AI computing.

Building on these themes, Johnny Zhang moderated a panel discussion on the future of data centers, resilience and digital infrastructure, bringing together industry experts from data center design, cloud and AI infrastructure, and cooling technology to explore emerging requirements for energy efficiency, high-density cooling and scalability. EPG Chief Technology Officer Enso Li also presented AI Core at the Energy Security & Efficiency Theatre, demonstrating how standardized modules and factory prefabrication can accelerate data center deployment.

Alongside these industry discussions, EPG continued to strengthen its global partnerships. The company signed cooperation agreements with international industry partners across AI data center planning, construction and delivery. These collaborations will support the development of next-generation data center infrastructure, broaden EPG’s ecosystem across the Asia-Pacific and expand its presence in global markets.

Complementing these industry engagements, EPG showcased its AI Core and Edge POD solutions across its exhibition space, welcoming visitors to explore its modular infrastructure offerings. AI Core takes a prefabricated, modular approach to AI infrastructure, integrating standardized power, cooling and other critical infrastructure modules to simplify deployment and enable flexible expansion as compute requirements grow. Built on this modular approach, EPG’s E Series offers configurable solutions tailored to different project requirements. One of its offerings, Edge POD, is an all-in-one solution for distributed computing environments where power availability and deployment speed are critical. Designed for 1–10 MW applications, Edge POD supports rapid deployment, low-latency computing and distributed redundancy.

EPG’s joint venture, MagPro, also introduced its new magnetic levitation chiller platform, AeroLev 1850. The 1.85 MW-class, air-cooled, magnetic-bearing chiller platform is designed for next-generation AI data centers in water-scarce, high-ambient environments, with chilled-water outlet temperatures of up to 45°C. Its cooling-tower-free architecture combines oil-free magnetic-levitation technology with intelligent controls to deliver efficient, reliable cooling while reducing water consumption.

The launch of AeroLev 1850 marks a strategic milestone in EPG’s global cooling technology roadmap. Established in May 2026, MagPro brings together EPG’s data center engineering and global delivery expertise with CIGU’s magnetic-levitation technology and R&D capabilities. The partnership expands EPG’s portfolio into advanced cooling to address the demands of high-density AI computing while reducing reliance on water-intensive cooling systems.

“AI computing is reshaping the infrastructure requirements of data centers,” said Alick Wan, Founder and Chairman of EPG. “Our focus extends beyond individual technological breakthroughs. By combining modular and standardized solutions with global delivery capabilities, we aim to help customers deploy and scale computing infrastructure efficiently across markets. We will continue working with global partners to build more efficient and resilient infrastructure for the next generation of digital growth.”

Looking ahead, EPG will continue to evolve its solutions and strengthen its capabilities to meet the changing demands of the data center industry.

Learn more: https://www.epg-module.com/

CONTACT: communications@epg-module.com

About EPG

EPG is a prefabricated modular data center infrastructure provider, powered by R&D centers in Singapore, Malaysia, and Shanghai, as well as six advanced manufacturing hubs in Malaysia and China. With over 20 years of engineering expertise, it has a workforce of more than 1,600 employees, including nearly 300 researchers and experienced engineers in its R&D and technical team. Through continuous technological innovation and a scalable delivery system, EPG delivers  integrated and efficient data center solutions for hyperscale, cloud, and enterprise deployments across APAC, EMEA, and other global markets.

About MagPro (Nanjing CIPU Technology Co., Ltd.)

MagPro is a joint venture between CIGU Technology Corp. Ltd. and EPG Data Technology (Shanghai) Co., Ltd., specializing in the research, development, and production of reliable, energy-efficient cooling and air-conditioning systems for AI data centers, cloud, and hyperscales. MagPro operates a more than 6,000-square-meter production base and two air-cooled laboratories, supporting testing of air-cooled units up to 2,000 kW.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/epg-showcases-full-stack-aidc-capabilities-and-global-delivery-network-at-dcwa-2026-in-singapore-302913737.html

SOURCE EPG Global Technology (Shanghai) Co., Ltd.

Continue Reading

Trending